Adult Nodular Sclerosis Hodgkin Lymphoma Active Not Recruiting Phase 2 Trials for Brentuximab vedotin (DB08870)

IndicationStatusPhase
DBCOND0030887 (Adult Nodular Sclerosis Hodgkin Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01476410Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin LymphomaTreatment